SAN RAFAEL, Calif.,
Aug. 10, 2020 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced
that Jeff Ajer, Executive Vice
President and Chief Commercial Officer, and Brian Mueller, Executive Vice President, Chief
Financial Officer will participate in the 2020 Wedbush PacGrow
Healthcare Virtual Conference on August 11,
2020 at 10:55am ET and
Henry Fuchs, M.D., President,
Worldwide Research & Development and Brian Mueller, Executive Vice President, Chief
Financial Officer, will participate in the Canaccord Genuity 40th
Annual Growth Conference on August 13,
2020 at 1:00pm ET. An
audio webcast of the presentations will be available live. You can
access the webcast at: https://investors.biomarin.com/. An archived
version of the remarks will also be available through the Company's
website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for people with serious and
life-threatening rare disorders. The company's portfolio consists
of six commercialized products and multiple clinical and
pre-clinical product candidates.
For additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
Contacts:
|
|
Investors
|
Media
|
Traci
McCarty
|
Debra
Charlesworth
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301108236.html
SOURCE BioMarin Pharmaceutical Inc.